How to Buy Voyager Therapeutics Stock
Voyager Therapeutics Inc
Voyager Therapeutics, Inc. , a gene therapy company, focuses on the development of treatments and next-generation platform technologies.
Voyager Therapeutics stock last closed at $7.62, up 2.7% from the previous day, and has increased 2.42% in one year. It has overperformed other stocks in the Biotechnology industry by 0.25 percentage points. Voyager Therapeutics stock is currently +25.74% from its 52-week low of $6.06, and -46.86% from its 52-week high of $14.34.
At the moment, there are 54.3M VYGR shares outstanding. The market cap of VYGR is $413.77M. In the last 24 hours, 345,051 VYGR shares were traded.
How to Buy Voyager Therapeutics Stock
Not sure how to invest in Voyager Therapeutics stock? Here's how.
- Choose where to buy Voyager Therapeutics stock: You need to pick an online brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you decide where to buy Voyager Therapeutics stock.
- Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Fund your brokerage account: Pick your method of payment and add your info.
- Evaluate Voyager Therapeutics stock: The Voyager Therapeutics ticker symbol is VYGR. Is Voyager Therapeutics stock a good investment? Should you buy shares of VYGR? How do VYGR's underlying business fundamentals look? Do top analysts think Voyager Therapeutics is a good buy? Why has VYGR's stock price moved recently? (Hint: Our stock research tools can help you figure out if VYGR is a good stock to buy).
- Make your VYGR buy order: Decide if you will purchase VYGR shares at the current market price or use a limit order to purchase VYGR shares at a particular price.
- Track your investment in VYGR: Create a watchlist to key updates about your position in Voyager Therapeutics stock.
Step 1: Choose where to buy Voyager Therapeutics stock
You need a brokerage account in order to access the NASDAQ market and buy VYGR shares.
Our preferred brokerage: eToro
Based on our research, eToro is the best place to buy stocks. Here's why:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to global markets: From Technology to Utilities, New York to London — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro has a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by opening an account with eToro today.
Open eToro AccountStep 2: Open a brokerage account
Now that you've picked the right brokerage, the next step is to fill out some personal info so you are able to buy VYGR today.
How to Set Up a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to create your new trading account.
- Submit your details by pressing the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you have created your account on the best stock broker app, your next step is to transfer the money for your investment:
Watch the tutorial below to see the process of transferring money into your brokerage account.
Step 4: Evaluate Voyager Therapeutics stock
Once you have decided on the best place to buy Voyager Therapeutics stock, it's critical to evaluate their stock before you invest, so you can understand the risk as well as the opportunity.
Voyager Therapeutics quick stats
Fundamentals of Voyager Therapeutics
WallStreetZen was designed to help part-time investors perform more in-depth fundamental analysis quickly.
You can view all of the due diligence checks on VYGR's stock page.
Is VYGR stock undervalued or overvalued?
You can use many financial metrics, analyses, models, and charts to gauge VYGR's true value.
Using relative valuations methods:
- VYGR may be undervalued based on its P/E ratio of 2.47x, relative to Biotechnology industry P/E ratio of 14.88x
- VYGR may be undervalued based on its P/B ratio of 1.75x, relative to Biotechnology industry P/B ratio of 5.85x
- VYGR may be undervalued based on its PEG ratio of 0.03x
You can do more valuation analysis on VYGR's stock here.
How do VYGR Financials look?
Pros:
- There are more short-term assets than long-term liabilities on the VYGR balance sheet.
- There are more short-term assets than short-term liabilities on the VYGR balance sheet.
- Total VYGR debt is lower than 5 years ago, relative to shareholder equity.
- VYGR profit margin has gone up from -113.4% to 52.9% in the past year.
- VYGR earnings of $122.02M is not sufficient to cover its interest payments.
- VYGR's operating cash flow of $77.92M allows it to safely service it's debt of $0.00.
Cons:
- VYGR has a relatively high debt to equity ratio of 0.49.
Is it a good time to buy VYGR stock, according to Wall Street analysts?
Out of 4 Equities analysts who research VYGR, the consensus analyst rating on Voyager Therapeutics is a Strong Buy
Please keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
You can dig deeper into what analysts are saying on the Voyager Therapeutics stock forecast page.
Metrics for Advanced VYGR Traders
VYGR Revenue
Last year, VYGR earnings were $132.33M. In the last three year, VYGR's earnings have gone up by 128.28% per year. This was faster than the Biotechnology industry average of 17.13%.
Last year, VYGR revenue was $250.01M. During the last five year, VYGR's revenue has increased by 101.01% per year. This was faster than the Biotechnology industry average of 28.56%.
Find out more about VYGR's earnings and revenue performance here.
Who is buying/selling VYGR?
Over the last 12 months, insiders at VYGR have sold more shares than they have bought.
Alfred Sandrock, President and CEO of VYGR, was the latest VYGR insider to sell. They sold $119,453.90 worth of VYGR stock on Apr 2, 2024.
Research more about who owns VYGR stock here.
Can I get consistent income from VYGR stock?
No, Voyager Therapeutics doesn't provide an income stream by paying out dividends.
What do other traders have to say about VYGR?
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Make your VYGR buy order
There are two main options:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are mostly sufficient. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at an exact dollar amount limit, place a limit order.
Press the Open button and your broker will place your order.
If you need additional help investing in stocks on eToro, click the how to video below:
Step 6: Track your investment in VYGR
Now that you own some VYGR shares, you'll want to keep up with your investment.
Put VYGR on a watchlist to keep track of your VYGR stock.
VYGR Feed
How to Buy Stock in Voyager Therapeutics
To reiterate, here are the 6 steps to buy Voyager Therapeutics stock:
- Choose where to buy Voyager Therapeutics stock
- Open a brokerage account
- Fund your brokerage account
- Evaluate Voyager Therapeutics stock
- Make your VYGR buy order
- Track your investment in VYGR
If you need a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to get notifications regarding your new investment in Voyager Therapeutics, click the button below.
Other "How To" Guides You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.